Your browser doesn't support javascript.
loading
Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.
Wagner, Anna D; Lordick, Florian; Grabsch, Heike I; Terashima, Masanori; Terada, Mitsumi; Yoshikawa, Takaki; Boku, Narikazu; Kataoka, Kozo; Smyth, Elizabeth C; Mauer, Murielle; Haustermans, Karin; Moehler, Markus H.
Afiliação
  • Wagner AD; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: dorothea.wagner@chuv.ch.
  • Lordick F; University Cancer Center Leipzig, University Medicine Leipzig, Leipzig, Germany.
  • Grabsch HI; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands; Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
  • Terashima M; Division of Gastric Surgery, Shizuoka Cancer Center, Japan.
  • Terada M; Japan Clinical Oncology Group, Clinical Research Support Office and National Cancer Center Hospital, Tokyo, Japan.
  • Yoshikawa T; Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Boku N; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Kataoka K; Department of Surgery, Division of Lower GI, Hyogo College of Medicine, Hyogo, Japan.
  • Smyth EC; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Mauer M; EORTC Headquarters, Bruxelles, Belgium.
  • Haustermans K; Department of Radiotherapy and Oncology, University of Leuven, Leuven, Belgium.
  • Moehler MH; University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Eur J Cancer ; 124: 67-76, 2020 01.
Article em En | MEDLINE | ID: mdl-31759294
ABSTRACT
The aim of this manuscript is to discuss the viewpoint of the European Organisation for Research and Treatment of Cancer (EORTC) Gastric Cancer Taskforce and Japan Clinical Oncology Group (JCOG) Gastric Cancer Study Group on the current challenges in the multidisciplinary management of stage II-III gastric and gastro-oesophageal junction (GEJ) cancer. We seek to outline how these challenges are addressed in current trials of both groups. Key elements of future trials of EORTC and JCOG in this indication are described, and a joint vision on how multidisciplinary research of gastric and GEJ cancer patients should be organised is outlined.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Junção Esofagogástrica Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Junção Esofagogástrica Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article